Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema

NCT04894110 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Edema
Corneal Endothelial Dysfunction
Corneal Endothelial Dystrophy
Fuchs Dystrophy
Fuchs Endothelial Corneal Dystrophy
Pseudophakic Bullous Keratopathy
Bullous Keratopathy
Endothelial Dysfunction
Moderate Corneal Endothelial Decompensation

Interventions

BIOLOGICAL: EO2002
BIOLOGICAL: EO2002 low dose
BIOLOGICAL: EO2002 mid dose
BIOLOGICAL: EO2002 high dose

Sponsor

Emmecell